The Role of Finerenone in Cardiorenal Protection and Urine Albumin-to-Creatinine Ratio Modulation

. These recommendations emphasize its role in reducing the residual risk of CKD progression and CV complications. Finerenone represents an important advancement in the management of CKD and T2D, offering substantial benefits in UACR modulation and cardiorenal protection. By examining its clinical efficacy and safety profile, this review aims to provide a comprehensive understanding of how finerenone contributes to improved outcomes for patients with CKD and T2D, emphasizing its position as a pivotal component of contemporary treatment strategies.